Androgenic Alopecia is one of the most common causes of hair loss. Most youngsters are suffering from hair loss and Minoxidil is the only FDA-approved drug often prescribed by doctors to treat hair loss. But, minoxidil takes around 6-8 months to show the results. Patients receiving hair loss treatment should wait a long to see the results. Minoxidil shows variable response because of altered sulphotransferase enzyme activity. Studies have shown that around 60% of the global population has low sulphotransferase enzyme because of mutations in SULT1A1 gene. Minoxidil is a prodrug and needs to be activated by sulphotransferase into minoxidil sulphate. 
People with low sulphotransferase enzymes will not respond to minoxidil for hair loss treatment.
Trichogene, An Indian-based startup company first introduced Minoxidil Response Test (MRT) that determines whether a person responds to minoxidil treatment or not with 100% accuracy by analyzing SULT1A1 gene variants responsible for low sulphotransferase activity. MRT helps doctors to provide more precise precision hair loss treatment for Androgenic Alopecia. Founders of Trichogene Dr.M. Sai Babu and Mohd.Rizwan Younus found that variable response to minoxidil became the biggest challenge for doctors while treating patients with minoxidil. If doctors know about minoxidil response before starting treatment, It would be easy to provide optimized treatment. The founders of Trichogene have developed Minoxidil Response Test for a very affordable price.MRT can provide results in 7 working days. A simple buccal swab sample is enough to know the minoxidil response. Once the sample reaches the lab.DNA will be extracted from the buccal swab sample and the SULT1A1 gene will be analyzed by molecular biology techniques. Within 7 working days, the MRT report will be ready.
Read More: The Start-Up That’s Making Healthcare More Accessible To Corporate India
MRT is easy, fast, and accurate, and also available all over India. We are offering this expensive test for a very affordable price and made it available to the common man who is planning to take hair loss treatment – said the founders of Trichogene.
